相关实验视频
Updated: Jun 11, 2025

07:44
A Porcine Model of Acute Autologous Pulmonary Embolism
Published on: September 6, 2024
307
中级和高风险肺栓塞的风险分层和管理
Sanaullah Mojaddedi1,2, Javairia Jamil3, Daniel Bishev1,2
1College of Medicine, University of Central Florida, Graduate Medical Education, Orlando, FL 32827, USA.
Journal of clinical medicine
|September 28, 2024
概括
急性肺栓塞 (PE) 带来了显著的死亡风险和长期并发症. 本综述审查了高风险和中等风险PE的先进疗法,评估了当前的证据和正在进行的临床试验.
科学领域:
- 心脏病学 心脏病学
- 肺部病理学 肺部病理学
- 血管医学 血管医学
背景情况:
- 急性肺栓塞 (PE) 是死亡的主要原因,并可能导致长期问题,如后PE综合征.
- 现有的风险分层工具无法预测短期恶化和长期后果.
- 系统性血栓溶解虽然是高风险PE的传统,但具有相当大的出血风险.
研究的目的:
- 审查高风险和中等风险PE中先进疗法的证据.
- 总结正在进行的研究这些先进治疗方法的临床试验.
主要方法:
- 对PE先进疗法的现有证据的文献综述.
- 从随机对照试验和观察性研究中分析数据.
- 在PE管理当前和即将到来的临床试验的摘要.
主要成果:
- 与系统性血栓溶解相比,导向于导管的干预措施具有较低的出血风险.
- 目前仅有有限的随机试验数据可充分支持导管干预的有效性.
- 目前正在进行的试验旨在为先进的PE疗法提供强有力的证据.
结论:
- 先进的疗法,包括导管干预,越来越多地用于高风险和中等风险的PE.
- 进一步的研究和随机对照试验对于确定这些干预措施的最终作用和最佳使用至关重要.
- 需要改善风险分层和基于证据的治疗策略,以减轻PE死亡率和发病率.
相关概念视频
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
3
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
3
Pulmonary Embolism III: Nursing Management
6
A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...
6
Pulmonary Embolism I: Introduction
2
Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
2
Venous Thrombosis III: Interprofessional Care
3
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
3
Venous Thrombosis IV: Nursing Management
3
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
3
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
155
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
155

